Kukje Pharma Co Ltd (002720) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Kukje Pharma Co Ltd (002720) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.99 Billion ≈ $3.38 Million USD) by net assets (₩95.32 Billion ≈ $64.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002720 net asset quality score to measure how much of total assets are equity-financed.

Kukje Pharma Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Kukje Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Kukje Pharma Co Ltd (002720) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Kukje Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kukje Pharma Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Base Carbon Inc. NEO:BCBN	-0.021x
M K Land Holdings Bhd KLSE:8893	-0.012x
Makina Takim Endustrisi AS IS:MAKTK	-0.038x
Medico Remedies Limited NSE:MEDICO	0.009x
Renishaw PLC LSE:RSW	0.040x
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- F:BLH	0.003x
Unlu Yatirim Holding AS IS:UNLU	-0.041x
Sinmah Capital Bhd KLSE:9776	-0.137x

Annual Cash Flow Conversion Efficiency for Kukje Pharma Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Kukje Pharma Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Kukje Pharma Co Ltd (002720) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩89.55 Billion ≈ $60.69 Million	₩3.94 Billion ≈ $2.67 Million	0.044x	+4.54%
2023-12-31	₩84.95 Billion ≈ $57.57 Million	₩3.58 Billion ≈ $2.42 Million	0.042x	-52.06%
2022-12-31	₩74.08 Billion ≈ $50.20 Million	₩6.50 Billion ≈ $4.41 Million	0.088x	-37.26%
2021-12-31	₩68.59 Billion ≈ $46.48 Million	₩9.60 Billion ≈ $6.50 Million	0.140x	+93.42%
2020-12-31	₩70.50 Billion ≈ $47.78 Million	₩5.10 Billion ≈ $3.46 Million	0.072x	+22.36%
2019-12-31	₩60.95 Billion ≈ $41.31 Million	₩3.60 Billion ≈ $2.44 Million	0.059x	-69.34%
2018-12-31	₩68.70 Billion ≈ $46.56 Million	₩13.25 Billion ≈ $8.98 Million	0.193x	+1562.80%
2017-12-31	₩67.78 Billion ≈ $45.93 Million	₩786.10 Million ≈ $532.73K	0.012x	-95.14%
2016-12-31	₩67.52 Billion ≈ $45.76 Million	₩16.10 Billion ≈ $10.91 Million	0.238x	+421.30%
2015-12-31	₩68.46 Billion ≈ $46.39 Million	₩-5.08 Billion ≈ $-3.44 Million	-0.074x	-6075.28%
2014-12-31	₩50.85 Billion ≈ $34.46 Million	₩-61.11 Million ≈ $-41.41K	-0.001x	+98.47%
2013-12-31	₩58.33 Billion ≈ $39.53 Million	₩-4.60 Billion ≈ $-3.11 Million	-0.079x	-376.04%
2012-12-31	₩55.35 Billion ≈ $37.51 Million	₩1.58 Billion ≈ $1.07 Million	0.029x	-87.72%
2011-12-31	₩74.79 Billion ≈ $50.69 Million	₩17.39 Billion ≈ $11.78 Million	0.232x	--

About Kukje Pharma Co Ltd

KO:002720 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.81 Million

₩64.65 Billion KRW

Market Cap Rank

#22331 Global

#1374 in Korea

Share Price

₩3175.00

Change (1 day)

+4.27%

52-Week Range

₩3045.00 - ₩5230.00

All Time High

₩12612.03